Martha Morrell, MD, PhD

Publication Details

  • Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs EPILEPSY & BEHAVIOR Pack, A. M., Morrell, M. J., McMahon, D. J., Shane, E. 2011; 21 (4): 453-458

    Abstract:

    Relationships between reproductive hormone levels, bone turnover marker levels, bone mineral density, and rates of bone loss were evaluated in premenopausal women with epilepsy taking enzyme-inducing antiepileptic drugs (EIAEDs: phenytoin or carbamazepine) or lamotrigine. Calciotropic and reproductive hormone levels, bone turnover marker levels, and bone mineral density were measured at baseline and 1 year. Bone mineral density did not differ between groups. Serum calcium (P<0.001) and estrone (P<0.001) levels were lower in the EIAED group. Sex hormone-binding globulin levels were higher (P<0.001) and percentage free estradiol levels were lower (P<0.001) in the EIAED group. We detected no relationship between bone mineral density change and calciotropic hormone or bone turnover marker levels. Women with higher sex hormone-binding globulin and lower free estradiol levels sustained more bone loss at the total hip (P=0.04 and P=0.02) and a trend toward more bone loss at the lumbar spine (P=0.07 and P=0.08). These findings suggest that lower estrogen levels may contribute to bone loss in premenopausal women with epilepsy.

    View details for DOI 10.1016/j.yebeh.2011.05.001

    View details for Web of Science ID 000294104900024

    View details for PubMedID 21704565

Stanford Medicine Resources:

Footer Links: